Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Promoting Drug Safety Through Latest Advancements in Pharmacovigilance
  • USA - English


News provided by

OMICS Group Inc.

Jun 25, 2014, 14:00 ET

Share this article

Share toX

Share this article

Share toX

Plenary Session by Dr. K.C Singhal, Chief Patron, Society of Pharmacovigilance, India.
Plenary Session by Dr. K.C Singhal, Chief Patron, Society of Pharmacovigilance, India.

Los Angeles, CA (PRWEB) June 25, 2014 -- Pharmacovigilance -2014 is intended to gather the renowned people under the same platform to share their advanced research about pharmacy, clinical trials, adverse drug reaction, pharmacokinetics, pharmacodynamics, pharmacoepidemiology, case report in clinical trials and related scientific projects.

This International Pharma Conferences is a unique platform for research as this domain is emerging very fast and steady. The international conference is expected to encourage researchers to promote and exchange ideas and knowledge at conference.

Accelerating requirement for Pharmacovigilance clarifies us that 'No medicinal product is entirely or absolutely safe for all people, in all places, at all times. We must always live with some measure of uncertainty'.

Post this

The important sessions at this International Pharma Conference include Pharmacovigilance and its Challenges, Role of Clinical Trials, Clinical Trials on Diseases, Adverse Drug Reactions, Pharmacokinetics and Pharmacodynamics, Pharmacy Practices and its Challenges, Risk Management: New Approaching Paradigm for Pharmacovigilance, Clinical Research and Statistics, Strategies for Growth in Pharma Environment, Good Pharmacovigilance Practice and Pharmacoepidemiology, Case Report in Clinical Trials.

Several renowned scholars and researchers like K. C. Singhal, Society of Pharmacovigilance, India; J Vijay Venkatraman, Oviya MedSafe Pvt. Ltd. India; Suresh Bowalekar, PharmaNet/i3, India; Prakash V Diwan, Indian Pharmacological Society, India; Ram Sharnagat Thakur, Krupanidhi College of Pharmacy, India; S. Duraivel, Nimra College of Pharmacy, India; Y. Padmanabha Reddy, Raghavendra Institute of Pharmaceutical Education & Research, India; Dhananjay B. Meshram, Pioneer Pharmacy Degree College, India; Chander Mohan, RBIP, India are going to be part of Pharmacovigilance -2014 as speakers and presenters.

International Pharma Conferences are a result of great efforts of OMICS Group that offers a unique platform for several attractive International Workshops on the latest outcomes in this domain by Dr. V. Kalaiselvan, Principal Scientific Officer, Indian Pharmacopoeia Commission, India.

Pharmacovigilance-2014 will experience a Plenary Session by Dr. K.C. Singhal, Chief Patron, Society of Pharmacovigilance, India.

OMICS Group is home for 350 open access scholarly journals and more than 150 international scientific meetings around the globe. These conferences encourages the young researchers and scholars to interact with the world class experts in relevant fields to evaluate their research through its Young Research Forum, Best Poster award competition and Student fellowship.

The Collaborators for Pharmacovigilance-2014 are Physics, Learning Academy, Faculty of Health sciences as media partner. The supporting journals of Pharmacovigilance -2014 conference are Journal of Pharmacovigilance, Journal of Clinical Trials, Journal of Clinical & Experimental Pharmacology, Journal of Diagnostic Techniques and Biomedical Analysis.

Pharmacovigilance-2014 is a unique platform for exchange of thoughts and recent developments for safer use of drugs, this knowledge will be disseminated through organizing International Pharma Conferences thereby creating the awareness and benefit about the upcoming challenges and progress in the field of Pharmacovigilance and drug safety issues.

For more details about the 3rd International conference on Pharmacovigilance. Please follow the link: http://www.pharmaceuticalconferences.com/pharmacovigilance-clinical-trials-2014/index.php.

Rahul Kumar
Pharmacovigilance-2014 Organizing Committee
Pharmaceutical Conferences
5716 Corsa Ave, Suite110
Westlake, Los Angeles
CA-91362-7354, USA
Office +1- 650-268-9744
Toll No +1-800-216-6499 (USA & Canada)
E-mail: pharmavigilance2014(at)omicsgroup(dot)us

Issac Samuel, OMICS Group Inc., http://www.omicsonline.org, +1 8888438169, [email protected]

Modal title

Pharmacovigilance-2014 Conference Guide
View PDF
Pharmacovigilance-2014 Conference Guide
Pharmacovigilance-2014 Brochure
View PDF
Pharmacovigilance-2014 Brochure
Pharmacovigilance-2014 Conference Guide Pharmacovigilance-2014 Brochure

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.